Literature DB >> 2817079

Biological grading of breast cancer using antibodies to proliferating cells and other markers.

S S Bacus1, R Goldschmidt, D Chin, G Moran, D Weinberg, J W Bacus.   

Abstract

Quantitation of immunohistochemical staining by image analysis was performed on 50 breast cancers stained with the monoclonal antibody Ki-67 to determine the growth fraction and its correlation with tumor grade. A high degree of correlation was shown. For each case the DNA ploidy was determined by quantitation of the DNA Feulgen stain by computerized microdensitometry. DNA content of breast tumor cells correlated to the histopathologic grade at which poorly differentiated tumors are more likely to be aneuploid. Quantitation of immunohistochemistry for estrogen and progesterone receptors had a high degree of correlation with the steroid binding assay, such as dextran-coated charcoal assay (DCCA), and were weakly correlated to histologic grade. In summary, our results indicated that quantitation of Ki-67-positive nuclear area and of DNA content by image analysis provides an objective method for assessing tumor cell growth fraction and DNA ploidy. Quantitation of steroid receptors by immunohistochemistry is a better and easier technique than those currently used to determine the best therapy for postmenopausal women. These methods can be performed on small frozen sections or needle aspirates in quantities that are insufficient for current steroid binding assays. Thus, this method is prognosticly useful even for patients with small breast lesions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817079      PMCID: PMC1880091     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.

Authors:  J S Meyer; W C Bauer; B R Rao
Journal:  Lab Invest       Date:  1978-09       Impact factor: 5.662

2.  DNA image cytometry on machine-selected breast cancer cells and a comparison between flow cytometry and scanning cytophotometry.

Authors:  C J Cornelisse; A M Van Driel-Kulker
Journal:  Cytometry       Date:  1985-09

3.  A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.

Authors:  R W McDivitt; K R Stone; R B Craig; J S Meyer
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662

4.  Progression of mammary adenocarcinomas as reflected by nuclear DNA content.

Authors:  G U Auer; A G Fallenius; K Y Erhardt; B S Sundelin
Journal:  Cytometry       Date:  1984-07

5.  Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies.

Authors:  M Perrot-Applanat; F Logeat; M T Groyer-Picard; E Milgrom
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

6.  Prognostic factors in patients with stage I, estrogen receptor-negative carcinoma of the breast. A clinicopathologic study.

Authors:  T W Bauer; D O'Ceallaigh; J C Eggleston; G W Moore; R R Baker
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

7.  Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.

Authors:  G Auer; E Eriksson; E Azavedo; T Caspersson; A Wallgren
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

8.  Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy.

Authors:  S J Schnitt; J L Connolly; J R Harris; S Hellman; R B Cohen
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

9.  Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.

Authors:  W J King; E R DeSombre; E V Jensen; G L Greene
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  15 in total

1.  Comparison of different detection methods in quantitative microdensitometry.

Authors:  L Ermert; A C Hocke; H R Duncker; W Seeger; M Ermert
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 2.  How malignant is malignant? A brief review of the microscopic assessment of human neoplasms, and the prediction of whether they will metastasize and kill.

Authors:  I Carr; N Pettigrew
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

Review 3.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

4.  Cyclin E, a redundant cyclin in breast cancer.

Authors:  J Gray-Bablin; J Zalvide; M P Fox; C J Knickerbocker; J A DeCaprio; K Keyomarsi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

5.  Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.

Authors:  H Kawamoto; H Koizumi; T Uchikoshi
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.

Authors:  W Domagala; J Lasota; A Dukowicz; M Markiewski; G Striker; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

7.  Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.

Authors:  H Kreipe; P Alm; H Olsson; M Hauberg; L Fischer; R Parwaresch
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Immunohistochemical expression of dog TERT in canine testicular tumours in relation to PCNA, ki67 and p53 expression.

Authors:  N Papaioannou; D Psalla; M Zavlaris; P Loukopoulos; N Tziris; I Vlemmas
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

9.  DNA ploidy and proliferating cell nuclear antigen in colonic adenomas and adenocarcinomas.

Authors:  T Tomita
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

10.  HER-2/neu oncogene expression and proliferation in breast cancers.

Authors:  S S Bacus; S G Ruby; D S Weinberg; D Chin; R Ortiz; J W Bacus
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.